Downturn for top biopharma companies Q3 market cap as Covid-19 vaccine demand falls
The top 20 global biopharmaceutical companies exhibited a downward trend in aggregate market capitalisation by from trillion in Q2 2022 to trillion in Q3, according to GlobalData’s Pharma Intelligence Center Companies This downturn in market cap…
Read More